Curanex Pharmaceuticals(CURX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CURX Curanex Pharmaceuticals

交易中 06-22 09:57:51 EDT

0.2886

+0.0086

+3.07%

最高0.2890	最低0.2866	成交量4.05万
今开0.2890	昨收0.2800	日振幅0.86%
总市值817.92万	流通市值262.43万	总股本2,834万
成交额1.17万	换手率0.45%	流通股本909.31万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":0.2886,"timestamp":1782136308460,"preClose":0.28,"halted":0,"volume":40535,"delay":0,"changeRate":0.030714285714285697,"floatShares":9093100,"shares":28340800,"eps":-0.255,"marketStatus":"交易中","change":0.0086,"latestTime":"06-22 09:57:51 EDT","open":0.289,"high":0.289,"low":0.2866,"amount":11701.7110881,"amplitude":0.008571,"askPrice":0.3064,"askSize":100,"bidPrice":0.2886,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.255,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782158400000},"marketStatusCode":2,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":0.28,"preHourTrading":{"tag":"盘前","latestPrice":0.295,"preClose":0.28,"latestTime":"09:19 EDT","volume":524,"amount":154.8435982,"timestamp":1782134377243,"change":0.015,"changeRate":0.053571,"amplitude":0.155357},"postHourTrading":{"tag":"盘后","latestPrice":0.308,"preClose":0.28,"latestTime":"19:54 EDT","volume":24606,"amount":6883.4644,"timestamp":1781826847213,"change":0.028,"changeRate":0.1,"amplitude":0.244736},"volumeRatio":4.941038},"requestUrl":"/m/hq/s/CURX/tweets","defaultTab":"tweets","newsList":[{"id":"1174946342","title":"Curanex制药公司：推进Phyto-N，计划于2026年第四季度向FDA提交针对溃疡性结肠炎的研究性新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1174946342","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174946342?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:54","pubTimestamp":1778763262,"startTime":"0","endTime":"0","summary":"Curanex制药公司正稳步推进其候选药物Phyto-N的开发进程。公司计划在2026年第四季度向美国食品药品监督管理局（FDA）提交针对溃疡性结肠炎的研究性新药申请。这一关键步骤标志着该药物向临床试验阶段迈出了重要的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608803303","title":"Curanex Pharmaceuticals Inc盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608803303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608803303?lang=zh_cn&edition=full","pubTime":"2026-02-03 23:03","pubTimestamp":1770130987,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日23时03分，Curanex Pharmaceuticals Inc股票出现异动，股价急速拉升5.33%。截至发稿，该股报0.350美元/股，成交量7.0123万股，换手率0.25%，振幅7.47%。Curanex Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.91%。Curanex Pharmaceuticals Inc公司简介：Curanex Pharmaceuticals Inc致力于发现、开发和商业化植物性药物，用于治疗炎症性疾病患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203230307a6cf0ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203230307a6cf0ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594402978","title":"Curanex Pharmaceuticals Inc盘中异动 早盘急速下跌7.60%报0.395美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594402978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594402978?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:32","pubTimestamp":1766586754,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日22时32分，Curanex Pharmaceuticals Inc股票出现波动，股价快速下跌7.60%。截至发稿，该股报0.395美元/股，成交量6953股，换手率0.02%，振幅1.94%。Curanex Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.24%。Curanex Pharmaceuticals Inc公司简介：Curanex Pharmaceuticals Inc致力于发现、开发和商业化植物性药物，用于治疗炎症性疾病患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122422323497a0a66d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122422323497a0a66d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curanexpharma.com","stockEarnings":[{"period":"1week","weight":-0.1691},{"period":"1month","weight":-0.0728},{"period":"3month","weight":-0.389},{"period":"6month","weight":-0.2531},{"period":"1year","weight":-0.93},{"period":"ytd","weight":-0.1531}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curanex Pharmaceuticals Inc最初于2018年6月1日在纽约州注册成立，后来转变为特拉华州公司。Curanex是一家处于发展阶段的制药公司，致力于发现、开发和商业化创新的植物药物，以治疗患有炎症性疾病的患者，并开发可能为自身免疫性疾病、代谢性疾病和病毒感染等各个领域临床需求未得到满足的患者提供潜在益处的疗法。","exchange":"NASDAQ","name":"Curanex Pharmaceuticals","nameEN":"Curanex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Curanex Pharmaceuticals(CURX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Curanex Pharmaceuticals(CURX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Curanex Pharmaceuticals,CURX,Curanex Pharmaceuticals股票,Curanex Pharmaceuticals股票老虎,Curanex Pharmaceuticals股票老虎国际,Curanex Pharmaceuticals行情,Curanex Pharmaceuticals股票行情,Curanex Pharmaceuticals股价,Curanex Pharmaceuticals股市,Curanex Pharmaceuticals股票价格,Curanex Pharmaceuticals股票交易,Curanex Pharmaceuticals股票购买,Curanex Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Curanex Pharmaceuticals(CURX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Curanex Pharmaceuticals(CURX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}